 | • レポートコード：D0FE190047 • 出版社/出版日：Straits Research / 2020年2月13日 • レポート形態：英文、PDF、127ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：ICT |
| Single User（1名様用、印刷不可） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Multi User（5名様用） | ￥836,200 (USD5,650) | ▷ お問い合わせ |
| Enterprise Price（法人閲覧用） | ￥1,073,000 (USD7,250) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは新生児スクリーニングソフトウェアの世界市場について広く調査・分析し、イントロダクション、調査手法、市場動向、種類別（リアルタイムPCR新生児スクリーニングソフトウェア、MS/MSテクノロジー新生児スクリーニングソフトウェア、NGS新生児スクリーニングソフトウェア、その他）分析、用途別（疾患診断、管理＆監視、データ管理、意思決定支援）分析、エンドユーザー別（病院、クリニック＆診断センター）分析、地域別分析、企業概要などを含め、今後の市場展望をまとめております。 ・イントロダクション ・調査手法 ・市場動向 ・新生児スクリーニングソフトウェアの世界市場：種類別（リアルタイムPCR新生児スクリーニングソフトウェア、MS/MSテクノロジー新生児スクリーニングソフトウェア、NGS新生児スクリーニングソフトウェア、その他） ・新生児スクリーニングソフトウェアの世界市場：用途別（疾患診断、管理＆監視、データ管理、意思決定支援） ・新生児スクリーニングソフトウェアの世界市場：エンドユーザー別（病院、クリニック＆診断センター） ・新生児スクリーニングソフトウェアの世界市場：地域別 ・企業概要 |
Global Statistics Representing Newborn Screening Software Market Scenario
Newborn screening software is an emerging concept in the healthcare sector used for the early identification of genetic metabolic or infectious conditions in newborns that can cause mental retardation or serious health problems if left untreated. It is widely adopted by hospitals and clinics for the organization, storage, and analysis of newborn information and screening test results.
The global newborn screening software market is expected to grow at a CAGR of 8.1% during the forecast period, 2019–2026.
Intended Audience
Newborn Screening Software Service Providers
Hospitals
Nursing Homes
Diagnostic Centers
Software Developers
Technology/System Integrators
Government Organizations
Research Institutes
Increasing Incidence of Neonatal Diseases
The growing incidence of neonatal diseases has led to an upsurge in demand for newborn screening tests. According to the World Health Organization, 5.6 million children died before the age of five in 2016 – a decline compared to the 9.9 million figure in 2000; however, the proportion of under-five deaths in the newborn period increased from 41% to 46% during the same period. Furthermore, the proportion of neonatal deaths in under-five deaths is highest in developing economies, making it an issue of global concern. According to WHO, Southern Asia (39%) and sub-Saharan Africa (38%) account for the largest shares for newborn deaths, and five countries accounted for the highest number of new-born deaths.
Need for Detection of SMA & Other Innumodeficiencies Drives Growth of Real-Time PCR Newborn Screening Software Segment
By type, real-time PCR newborn screening software is expected to hold a significant market share during the forecast period, 2019–2026. The technology is used to screen for various immunodeficiencies and commonly used to identify spinal muscular atrophy (SMA). According to Genetic Home References, SMA affects one per 8,000 to 10,000 births worldwide; the condition results in significant motor disabilities, respiratory and nutritional compromise, and death in infancy or childhood in more than 50% of the affected children. Thus, the demand for real-time PCR newborn screening software is expected to increase with the growing need to detect SMA and other immunodeficiencies.
Rising Adoption for Early Detection, Diagnosis, & Treatment Drives Growth of MS/MS Technology Newborn Screening Software Segment
Detectable disorders such as metabolic disorders, hematologic disorders, and endocrinopathies, account for approximately 3,000 new cases of potentially fatal or debilitating diseases each year in the U.S., for which outcomes are enhanced with early identification and treatment through newborn screening. The significant increase in the number of inherited metabolic disorders detectable in the newborn period because of tandem MS screening greatly extends the possibilities of early, usually presymptomatic, diagnosis, and treatment to minimize morbidity and mortality for many affected children.
Need for Detection of Gene Mutations Drive Growth of NGS Newborn Screening Software Segment
Next-generation sequencing (NGS) newborn screening software is likely to grow at an accelerated pace during the forecast period, 2019–2026. It is advanced software used in the diagnosis of inherited metabolic diseases. It is used as the second-tier diagnostic test to detect gene mutations in samples after the diagnosis of high-risk infants found by MS/MS technology. Thus, the genomic sequencing technologies are experiencing rapid developments, due to which the cost of genetic analysis has decreased, and the adoption of the technology is increasing in newborn screening.
Colossal Data Generation in Newborn Screening Drives Growth of Data Management Segment
By application, the data management segment is expected to grow at the highest CAGR in the global newborn screening software market during the forecast period, 2019–2026. Newborn screening started about 50 years ago in the developed countries of North America and Europe; at the time, data was recorded manually. Nowadays, newborn screening creates a large amount of data per patient. For instance, in the U.S.,
The adoption rate of newborn screening is 99%
There were around 3.79 million births in 2018
Newborns are screened for 60 different health conditions
Therefore, the amount of data created is large. Newborn screening software manages large volumes of data, from daily examinations and record-keeping; thus, the data management segment is expected to witness significant growth in years to come.
Rising Prevalence of Home Births to Drive Adoption of Newborn Screening Software in Clinics & Diagnostics Centers
Clinics and diagnostics centers are expected to hold a strong market share in the global newborn screening market during the forecast period, 2019–2026. In recent years, home birth trends are increasing around the world; according to the CDC, in the U.S., home birth rate rose 50% during 2004–2012. Thereby, the demand for newborn screening software in clinics and hospitals is thus rising with the growing prevalence of home births around the world.
Hospitals to Remain Key Adopters of Newborn Screening Software, Specifically in Developed Countries Where Adoption of Newborn Screening is Higher
The demand for newborn screening software is increasing in hospitals across developed economies as screening tests are normally included in the forms for standard medical procedures at hospitals. In grow countries such as the U.S. and U.K., the adoption rate of newborn screening is higher than 99% and hospitals are extensively adopting newborn screening software in order to track and monitor newborn screening as well as for disease diagnosis. Thus, the adoption of newborn screening in hospitals is increasing around the globe, which is positively affecting the growth of the hospitals segment in the newborn screening software market.
The U.S. to Spearhead Demand for Newborn Screening Software in North America Market
North America is projected to a significant share in the global new-born screening market, with the U.S. accounting for the largest share of the regional market. According to the CDC, around 4 million infants are born in the U.S. each year; in 2017, the country’s birth rate was 11.8 per 1,000. In order to maintain uniformity throughout the U.S., the Health Resources and Services Administration (HRSA) agreed upon a ‘Uniform Panel’ of 35 specific conditions that are currently recommended for incorporation into state screening programs and the cost for these supplemental screening tests is typically covered by insurance. As newborn screening is a law-abiding aspect in the U.S., the demand for newborn screening software is foreseen to remain strong in the country.
High Percentage of GDP Expenditure on Healthcare Drives Growth of Newborn Screening Software in Europe
Europe is expected to witness significant growth in the newborn screening software market on account of high GDP expenditure on healthcare, per capita expenditure, awareness, and income. In France, newborn screening is mandatory for five congenital diseases; thus, the demand for newborn screening software is rising in the country. In the U.K., newborns are screened for at least 9 conditions, and in Germany, the new-born screening process is centralized, and 99% of newborns are tested.
Favorable Healthcare Schemes to Drive Adoption of Newborn Screening Software in APAC
Asia-Pacific is expected to grow at an accelerated pace in the global new-born screening software market. Awareness programs and quality assurance of newborn diagnostic process have gained importance in the developing economies of Asia-Pacific. Countries such as Australia, New Zealand, Japan, the Philippines, Taiwan, South Korea, India, P.R. China, and Singapore are among the key contributors to the region’s growth momentum. Developing economies in the region are extensively adopting newborn screening and initiating newborn screening programs for selected metabolic and other congenital disorders. For instance, in Singapore, The KKH Women’s & Children’s Hospital Department of Pathology & Laboratory Medicine has been moving forward with the expansion of its newborn screening program, with plans to include congenital adrenal hyperplasia and severe combined immune deficiency. Thus, favorable healthcare schemes by government agencies are driving the newborn screening software market in Asia-Pacific.
Rising Awareness About Newborn Screening & Development of Healthcare Infrastructure to Propel Demand for Newborn Screening Software in LATAM
Latin America encompasses 20 countries with vast diversity in their healthcare systems. According to the World Bank, three Latin American countries are high income, and 16 are middle income while the remaining are low income. Out of 20 countries, 15 have national or regional NBS programs, only two have <3.0% coverage, and 10/15 have >75% coverage. Growing awareness about newborn screening and development of the healthcare system are accelerating the demand for newborn screening software in the region.
Saudi Arabia, Qatar, and Lebanon to Drive Growth of MEA Market
The Middle East and Africa region accounts for 6% of the global population. Saudi Arabia, Qatar, and Lebanon are regional pioneers for the adoption of newborn screening by tandem mass spectrometry (KSA), homocystinuria and TREC-KREK screening (QATAR), and G6PD screening. The demand for newborn screening software is, therefore, expected to remain high in specifically Saudi Arabia, Qatar, and Lebanon in the MEA market.
Recent Developments
In April 2019, the Utah Public Health Laboratory successfully deployed OMNI-Lab NBS v11.7 for its mass spectrometer program
In May 2019, Masimo partnered with Shenzhen Mindray Bio-Medical Electronics Co., Ltd. and entered into a purchase and license agreement to expand its business in Europe, the Middle East, Russia, and Asia-Pacific
In August 2019, BMD Software introduced Tandem Mass Spectrometry for the screening of congenital hypothyroidism in newborns
In July 2018, Bio-Rad Laboratories launched scATAC-Seq solution to profile thousands of cells
In January 2017, OZ Systems, along with Virginia, launched the electronic data exchange tool as a part of a multi-state, federally funded project to reduce delays in blood spot screening
In December 2017, PerkinElmer acquired Euroimmun AG, a German company, for a total of USD 1400 million
Key Players
Some of the prominent players in the global newborn screening software market are Astoria Pacific, Bio Rad, Masimo, NeoScreen, Northgate, OMNI Lab NBS, OZ Systems, PerkinElmer, SCIEX, Shimadzu, and Natus Medical Incorporate.
Newborn Screening Software Market Segmentation
By Type
Real-time PCR newborn screening software
MS/MS technology newborn screening software
NGS newborn screening software
Others
By Application
Disease diagnosis
Control and Monitoring
Data management
Decision support
By End-User
Hospitals
Clinics and diagnostic centers
By Region
North America
U.S.
Canada
Mexico
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
India
Japan
South Korea
Australia
Rest of Asia-Pacific
LATAM
Brazil
Argentina
Columbia
Rest of LATAM
Middle East
Saudi Arabia
Oman
Qatar
Bahrain
UAE
Rest of Middle East
Africa
Nigeria
Tanzania
South Africa
Ghana
Rest of Africa
TABLE OF CONTENTS
1 Introduction
1.1 Market Definition
1.2 Market Scope
2 Research Methodology
2.1 Primary Research
2.2 Research Methodology
2.3 Assumptions & Exclusions
2.4 Secondary Data Sources
3 Market Overview
3.1 Report Segmentation & Scope
3.2 Value Chain Analysis: Global Newborn Screening Software Market
3.3 Key Market Trends
3.3.1 Drivers
3.3.2 Restraints
3.3.3 Opportunities
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.4 Threat of Substitution
3.4.4 Threat of New Entrants
3.4.5 Competitive Rivalry
3.5 Market Share Analysis
4 Type Overview
4.1 Introduction
4.1.1 Market Size & Forecast
4.2 Real-time PCR Newborn Screening Software
4.2.1 Market Size & Forecast
4.3 MS/MS technology newborn screening Software
4.3.1 Market Size & Forecast
4.4 NGS newborn screening Software
4.4.1 Market Size & Forecast
4.5 Others
4.5.1 Market Size & Forecast
5 Application Overview
5.1 Introduction
5.1.1 Market Size & Forecast
5.2 Disease Diagnosis
5.2.1 Market Size & Forecast
5.3 Control and Monitoring
5.3.1 Market Size & Forecast
5.4 Data Management
5.4.1 Market Size & Forecast
5.5 Decision Support
5.5.1 Market Size & Forecast
6 End User Overview
6.1 Introduction
6.1.1 Market Size & Forecast
6.2 Hospitals
6.2.1 Market Size & Forecast
6.3 Clinics and diagnostic center
6.3.1 Market Size & Forecast
7 Regional Overview
7.1 Introduction
7.1.1 Market Size & Forecast
7.2 North America
7.2.1 Market Size & Forecast
7.2.2 U.S.
7.2.2.1 By Type
7.2.2.2 By Application
7.2.3 Canada
7.2.3.1 By Type
7.2.3.2 By Application
7.2.4 Mexico
7.2.4.1 By Type
7.2.4.2 By Application
7.3 Europe
7.3.1 Market Size & Forecast
7.3.2 Germany
7.3.2.1 By Type
7.3.2.2 By Application
7.3.3 France
7.3.3.1 By Type
7.3.3.2 By Application
7.3.4 U.K.
7.3.4.1 By Type
7.3.4.2 By Application
7.3.5 Italy
7.3.5.1 By Type
7.3.5.2 By Application
7.3.6 Spain
7.3.6.1 By Type
7.3.6.2 By Application
7.3.7 Russia
7.3.7.1 By Type
7.3.7.2 By Application
7.3.8 Poland
7.3.8.1 By Type
7.3.8.2 By Application
7.3.9 Rest of Europe
7.3.9.1 By Type
7.3.9.2 By Application
7.4 Asia-Pacific
7.4.1 Market Size & Forecast
7.4.2 Japan
7.4.2.1 By Type
7.4.2.1 By Application
7.4.3 China
7.4.3.1 By Type
7.4.3.2 By Application
7.4.4 Australia
7.4.4.1 By Type
7.4.4.2 By Application
7.4.5 India
7.4.5.1 By Type
7.4.5.2 By Application
7.4.6 South Korea
7.4.6.1 By Type
7.4.6.2 By Application
7.4.7 Vietnam
7.4.7.1 By Type
7.4.7.2 By Application
7.4.8 Indonesia
7.4.8.1 By Type
7.4.8.2 By Application
7.4.9 Malaysia
7.4.9.1 By Type
7.4.9.2 By Application
7.4.10 Singapore
7.4.10.1 By Type
7.4.10.2 By Application
7.4.11 Rest of Asia-Pacific
7.4.11.1 By Type
7.4.11.2 By Application
7.5 LATAM
7.5.1 Market Size & Forecast
7.5.2 Brazil
7.5.2.1 By Type
7.5.2.2 By Application
7.5.3 Argentina
7.5.3.1 By Type
7.5.3.2 By Application
7.5.4 Columbia
7.5.4.1 By Type
7.5.4.2 By Application
7.5.5 Rest of LATAM
7.5.5.1 By Type
7.5.5.2 By Application
7.6 Middle East
7.6.1 Market Size & Forecast
7.6.2 Saudi Arabia
7.6.2.1 By Type
7.6.2.2 By Application
7.6.3 Oman
7.6.3.1 By Type
7.6.3.2 By Application
7.6.4 Qatar
7.6.4.1 By Type
7.6.4.2 By Application
7.6.5 Bahrain
7.6.5.1 By Type
7.6.5.2 By Application
7.6.6 UAE
7.6.6.1 By Type
7.6.6.2 By Application
7.6.7 Rest of Middle East
7.6.7.1 By Type
7.6.7.2 By Application
7.7 Africa
7.7.1 Market Size & Forecast
7.7.2 Nigeria
7.7.2.1 By Type
7.7.2.2 By Application
7.7.3 Tanzania
7.7.3.1 By Type
7.7.3.2 By Application
7.7.4 South Africa
7.7.4.1 By Type
7.7.4.2 By Application
7.7.5 Ghana
7.7.5.1 By Type
7.7.5.2 By Application
7.7.6 Rest of Africa
7.7.6.1 By Type
7.7.6.2 By Application
8 Company Profile
8.1 Astoria Pacific
8.1.1 Company Overview
8.1.2 Financial Performance
8.1.3 Recent Developments
8.1.4 Product Portfolio
8.2 Bio Rad
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Recent Developments
8.2.4 Product Portfolio
8.3 Masimo
8.3.1 Company Overview
8.3.2 Financial Performance
8.3.3 Recent Developments
8.3.4 Product Portfolio
8.4 NeoScreen
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.4 Recent Developments
8.4.4 Product Portfolio
8.5 Northgate
8.5.1 Company Overview
8.5.2 Financial Performance
8.5.3 Recent Developments
8.5.4 Product Portfolio
8.6 OMNI Lab NBS
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.3 Recent Developments
8.6.4 Product Portfolio
8.7 OZ Systems
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Recent Developments
8.7.4 Product Portfolio
8.8 PerkinElmer
8.8.1 Company Overview
8.8.2 Financial Performance
8.8.3 Recent Developments
8.8.4 Product Portfolio
8.9 SCIEX
8.9.1 Company Overview
8.9.2 Financial Performance
8.9.3 Recent Developments
8.9.4 Product Portfolio
8.10 Shimadzu Natus Medical Incorporate
8.10.1 Company Overview
8.10.2 Financial Performance
8.10.3 Recent Developments
8.10.4 Product Portfolio
8.11 Shimadzu Natus Medical Incorporate
8.11.1 Company Overview
8.11.2 Financial Performance
8.11.3 Recent Developments
8.11.4 Product Portfolio
LIST OF TABLESTABLE 1 Global Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 2 Real-time PCR Newborn Screening Software, Newborn Screening Software Market Share by Region, 2016–2026 ($Million)
TABLE 3 MS/MS technology newborn screening Software, Newborn Screening Software Market Share by Region, 2016–2026 ($Million)
TABLE 4 NGS newborn screening Software, Newborn Screening Software Market Share by Region, 2016–2026 ($Million)
TABLE 5 Others, Newborn Screening Software Market Share by Region, 2016–2026 ($Million)
TABLE 6 Global Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 7 Global Newborn Screening Software Market Share Value, 2016–2026 ($Million)
TABLE 8 North America Newborn Screening Software Market Share Value by Country, 2016–2026 ($Million)
TABLE 9 North America Newborn Screening Software Market Share Value by Type, 2016–2026 ($Million)
TABLE 10 North America Newborn Screening Software Market Share Value by Application, 2016–2026 ($Million)
TABLE 11 U.S. Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 12 U.S. Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 13 Canada Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 14 Canada Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 15 Mexico Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 16 Mexico Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 17 Europe Newborn Screening Software Market Share Value by Country, 2016–2026 ($Million)
TABLE 18 Europe Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 19 Europe Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 20 Germany Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 21 Germany Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 22 France Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 23 France Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 24 U.K. Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 25 U.K. Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 26 Italy Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 27 Italy Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 28 Spain Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 29 Spain Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 30 Russia Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 31 Russia Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 32 Poland Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 33 Poland Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 34 Rest of Europe Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 35 Rest of Europe Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 36 Asia-Pacific Newborn Screening Software Market Share Value by Country, 2016–2026 ($Million)
TABLE 37 Asia-Pacific Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 38 Asia-Pacific Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 39 Japan Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 40 Japan Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 41 China Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 42 China Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 43 Australia Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 44 Australia Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 45 India Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 46 India Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 47 South Korea Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 48 South Korea Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 49 Vietnam Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 50 Vietnam Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 51 Indonesia Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 52 Indonesia Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 53 Malaysia Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 54 Malaysia Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 55 Singapore Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 56 Singapore Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 57 Rest of Asia-Pacific Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 58 Rest of Asia-Pacific Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 59 LATAM Newborn Screening Software Market Share Value by Country, 2016–2026 ($Million)
TABLE 60 LATAM Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 61 LATAM Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 62 Brazil Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 63 Brazil Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 64 Argentina Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 65 Argentina Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 66 Columbia Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 67 Columbia Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 68 Rest of LATAM Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 69 Rest of LATAM Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 70 MIDDLE EAST Newborn Screening Software Market Share Value by Country, 2016–2026 ($Million)
TABLE 71 MIDDLE EAST Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 72 MIDDLE EAST Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 73 Saudi Arabia Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 74 Saudi Arabia Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 75 Oman Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 76 Oman Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 77 Qatar Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 78 Qatar Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 79 Bahrain Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 80 Bahrain Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 81 UAE Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 82 UAE Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 83 Rest of MIDDLE EAST Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 84 Rest of MIDDLE EAST Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 85 AFRICA Newborn Screening Software Market Share Value by Country, 2016–2026 ($Million)
TABLE 86 AFRICA Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 87 AFRICA Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 88 Nigeria Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 89 Nigeria Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 90 Tanzania Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 91 Tanzania Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 92 South Africa Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 93 South Africa Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 94 Ghana Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 95 Ghana Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
TABLE 96 Rest of AFRICA Newborn Screening Software Market Share by Type, 2016–2026 ($Million)
TABLE 97 Rest of AFRICA Newborn Screening Software Market Share by Application, 2016–2026 ($Million)
LIST OF FIGURES
FIGURE 1 Global Newborn Screening Software Market Overview
FIGURE 2 Value Chain Analysis
FIGURE 3 Bargaining Power of Suppliers
FIGURE 4 Bargaining Power of Buyers
FIGURE 6 Threat of Substitution
FIGURE 6 Threat of New Entrants
FIGURE 7 Competitive Rivalry
FIGURE 8 Newborn Screening Software Market, Market Share Analysis, 2018
FIGURE 9 Global Newborn Screening Software Market, 2016–2026
FIGURE 10 U.S. Newborn Screening Software Market Share, 2016–2026 ($Million)
FIGURE 11 Canada Newborn Screening Software Market Share, 2016–2026 ($Million)
FIGURE 12 Mexico Newborn Screening Software Market Share, 2016–2026 ($Million)
FIGURE 13 Germany Newborn Screening Software Market Share, 2016–2026 ($Million)
FIGURE 16 France Newborn Screening Software Market Share, 2016–2026 ($Million)
FIGURE 16 U.K. Newborn Screening Software Market Share, 2016–2026 ($Million)
FIGURE 16 Italy Newborn Screening Software Market Share, 2016–2026 ($Million)
FIGURE 17 Spain Newborn Screening Software Market Share, 2016–2026 ($Million)
FIGURE 18 Rest of Europe Newborn Screening Software Market Share, 2016–2026 ($Million)
FIGURE 19 Japan Newborn Screening Software Market Share, 2016–2026 ($Million)
FIGURE 20 China Newborn Screening Software Market Share, 2016–2026 ($Million)
FIGURE 21 Australia Newborn Screening Software Market Share, 2016–2026 ($Million)
FIGURE 22 India Newborn Screening Software Market Share, 2016–2026 ($Million)
FIGURE 23 South Korea Newborn Screening Software Market Share, 2016–2026 ($Million)
FIGURE 24 Rest of Asia-Pacific Newborn Screening Software Market Share, 2016–2026 ($Million)
FIGURE 26 Saudi Arabia Newborn Screening Software Market Share, 2016–2026 ($Million)
FIGURE 26 South Africa Newborn Screening Software Market Share, 2016–2026 ($Million)
FIGURE 27 Brazil Newborn Screening Software Market Share, 2016–2026 ($Million)
FIGURE 28 Rest of LAMEA Newborn Screening Software Market Share, 2016–2026 ($Million)
FIGURE 29 Astoria Pacific: Revenue Analysis ($Million)
FIGURE 30 Astoria Pacific: Segment Revenue 2018(%)